Long-Term Outcomes in Eyes Receiving Fixed-Interval Dosing of Anti–Vascular Endothelial Growth Factor Agents for Wet Age-Related Macular Degeneration
2019 ◽
Vol 6
(2)
◽
pp. 1-7
2020 ◽
Vol 4
(11)
◽
pp. 1047-1053
◽